Clinical Trials Logo

Metabolic Disease clinical trials

View clinical trials related to Metabolic Disease.

Filter by:

NCT ID: NCT04582643 Completed - Metabolic Disease Clinical Trials

Pilot Test of a Healthy Metabolic Behaviour Tool

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

This study aims to validate and pilot test the short-term intervention effect of a newly developed healthy metabolic behaviour tool, named as the 6P tool, on dietary attitude/ practice and body weight changes over one month among overweight and obese women. A total of 50 women, aged 21-40 years, BMI ≥25 kg/m2, who are attending the preconception clinic and planning for a pregnancy over the next one year, will be invited to participate in this pilot study. The recruitment period is estimated to take up to 10 weeks, with subsequent 1 month follow-up visit.

NCT ID: NCT04556500 Completed - Metabolic Disease Clinical Trials

Turkish Version of the Affordance in the Home Environment for Motor Development-Toddler (AHEMD-T)

Start date: October 1, 2020
Phase:
Study type: Observational

This study aimed to translate the Affordance in the Home Environment for Motor Development -Toddler (AHEMD-T) into Turkish and examine its psychometric properties.

NCT ID: NCT04556487 Completed - Metabolic Disease Clinical Trials

Turkish Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)

Start date: October 1, 2020
Phase:
Study type: Observational

Environment which children live and grown is very important for the all development stages. In Turkey there is no measurement for home environment evaluation so our aim is to investigate the Psychometric Properties of the Turkish version of Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS) in a sample of Turkısh children.

NCT ID: NCT04518605 Completed - Clinical trials for Overweight and Obesity

Breakfast for Young Females

NyStart2
Start date: August 15, 2020
Phase: N/A
Study type: Interventional

Investigators will test the health effects of eating a dairy-based protein-rich breakfast or isocaloric breakfast and performing regular physical exercise training for 12 weeks in young overweight women (2 x 2 factorial design). Measurements of body composition, physical fitness, metabolic health parameters, faeces and urine metabolites, and food diary will be collected.

NCT ID: NCT04450810 Completed - Clinical trials for Periodontal Diseases

Role of NLRP3 in Periodontitis and Diabetes

Start date: June 1, 2014
Phase:
Study type: Observational

NLRP3 plays a key role in endothelial function and may be a link for the known interaction of periodontitis and diabetes. The investigators compared the impact of gingival health, periodontitis (CP), diabetes or of both diseases (CP +diabetes) on saliva and serum NLRP3levels.

NCT ID: NCT04318509 Completed - Metabolic Disease Clinical Trials

Market Research - Acceptability Study for a New PKU Protein Substitute

Start date: February 4, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.

NCT ID: NCT04309331 Completed - Metabolic Disease Clinical Trials

Market Research - Acceptability Trial for a New PKU Amino Acid Based Protein Substitute

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to demonstrate that a new protein substitute is acceptable and well tolerated in children with PKU.

NCT ID: NCT04282057 Completed - Clinical trials for Cardiovascular Risk Factor

Effects of Shockwave Therapy Versus Radiofrequency

Start date: February 22, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

NCT ID: NCT04206124 Completed - Obesity Clinical Trials

mTORC1 and Autophagy in Human Brown Adipocytes

mTORHBFC
Start date: November 1, 2016
Phase: N/A
Study type: Interventional

The long term goal is to identify the potential therapeutic targets for the treatment of obesity and its associated disorders by studying the driving factors of activation of brown adipose tissue (BAT) in human adults. Whereas activation of brown adipose tissue (BAT) in human adults has been considered as a potential therapeutic target to battle obesity since it was identified in 2009, the underlying mechanisms of beige adipocytes appearance in human adults is unclear. The objective of this proposal is to investigate the role of autophagy in mediating the inhibitory effect of mammalian target of rapamycin complex 1 (mTORC1) in regulating human brown adipocytes. The central hypothesis is that autophagy plays a critical role in regulating browning of white adipose tissue and mediates the beneficial effect of mTORC1 inhibition on thermogenesis in human brown adipocytes.

NCT ID: NCT04143568 Completed - Metabolic Disease Clinical Trials

Circulating Progenitor Cells Levels in Periodontal Disease Patients

Start date: February 1, 2016
Phase:
Study type: Observational

Recently, a key role played in the ethiology of periodontitis has been highlighted by a subtype of stem cells derived from bone marrow, the circulating endothelial progenitor cells (EPCs). EPCs possess the ability to express surface antigens of endothelial and hematopoietic stem cells and to assist in maintaining vascular integrity and the repair mechanism of the endothelium. Among the main markers for the analysis of EPCs levels are CD34+, CD133+ and the kinase insert domain-containing receptor (KDR). CD34+ and CD133+ originate from hematopoietic stem cell antigens whereas KDR is a specific marker of endothelial cells. More specifically, CD34+ and CD133+/ KDR+ allows less mature and mature EPCs to be evaluated.